Kareem Rashid Rumah
Leveraging our breakthrough discoveries in the pathogenesis of multiple sclerosis, we are dedicated to stopping the devastating consequences of this disease at its initial onset. NanoLytx Team: Edmondo Campisi Kareem Rashid Rumah
Read MoreChris Buser
BioCubic makes inexpensive, nanoscale tissue imaging data accessible to customers in discovery, clinical research, and diagnostics, enabling earlier and more precise diagnosis of diseases BioCubic Team: Chris Buser
Read MoreLili Xu
NYHQBIO has developed a multi-organ preservation platform for 24-hour heart, lung, and liver preservation and 72 hours for kidneys confirmed in small and large animals. New York Huaqi Bioengineering, LLC Team: Lili Xu
Read MoreWill Alston
Aermed is a care companion for chronic disease patients which supports symptom monitoring with clinically validated PROs, medication tracking, and patient education. Aermed Team: Will Alston
Read MoreLisette Fernandez
“Bedsores Be Gone,” The 1:1, Caregiver: Patient Positioner; a “double duty” medical device exclusively designed for 1 caregiver. When In Reality, Repositioning Demands Frequency! Bedsores Be Gone Team: Lisette Fernandez
Read MoreYunus Yukselten
The Rev protein is essential for HIV replication, and developing inhibitors that target Rev-Rev interactions could introduce a novel type of antiretroviral therapy. CureViva Therapeutics Team: Yunus Yukselten
Read MoreChoukri Ben Mamoun (ELIV5)
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben Mamoun
Read MoreJose Quiroz
Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology. Bow Therapeutics Team: George Georgiev Jose Quiroz
Read MoreWenyan Jiang
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development
Read MoreCharlotte D’Hulst
MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder
Read More